Biomedican | Dennis O'Neill | WeFunder

Trace cannabinoids; what's beyond THC and CBD?


Despite the known benefits of the lesser known cannabis
cannabinoid; their small percentage within the plant make it cost
prohibitive to extract meaningful quantity.
  Dennis O'Neill the President of
Biomedican joins Dan Humiston
to explain how their patented process helps them produce high
quantities of high quality, organic trace cannabinoids.   He
discusses their current equity crowdfunding campaign on
 WeFunder and how to invest in their
company's growth.


Produced by PodCONX


 


Raising Cannabis Capital -
https://podconx.com/podcasts/raising-cannabis-capital


Dan Humiston -
https://podconx.com/guests/dan-humiston


Dennis O'Neill -
https://podconx.com/guests/dennis-oneill


Biomedican -
http://Biomedican.com


WeFunder - https://wefunder.com/biomedican_inc